» Articles » PMID: 21547090

Public Health Perspectives of Preeclampsia in Developing Countries: Implication for Health System Strengthening

Overview
Journal J Pregnancy
Publisher Wiley
Date 2011 May 7
PMID 21547090
Citations 137
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Review of public health perspectives of preeclampsia in developing countries and implications for health system strengthening.

Methods: Literature from Pubmed (MEDLINE), AJOL, Google Scholar, and Cochrane database were reviewed.

Results: The prevalence of preeclampsia in developing countries ranges from 1.8% to 16.7%. Many challenges exist in the prediction, prevention, and management of preeclampsia. Promising prophylactic measures like low-dose aspirin and calcium supplementation need further evidence before recommendation for use in developing countries. Treatment remains prenatal care, timely diagnosis, proper management, and timely delivery. Prevailing household, community, and health system factors limiting effective control of preeclampsia in these countries were identified, and strategies to strengthen health systems were highlighted.

Conclusion: Overcoming the prevailing challenges in the control of preeclampsia in developing countries hinges on the ability of health care systems to identify and manage women at high risk.

Citing Articles

Pregnancy and liver-related outcomes after alcohol-associated hepatitis: A global multicenter study.

Cooper K, Patel A, Kaluri S, Devuni D Hepatol Commun. 2025; 9(3).

PMID: 40048443 PMC: 11888976. DOI: 10.1097/HC9.0000000000000663.


Current Approaches and Innovations in Managing Preeclampsia: Highlighting Maternal Health Disparities.

Dickerson A, Joseph C, Kashfi K J Clin Med. 2025; 14(4).

PMID: 40004721 PMC: 11856135. DOI: 10.3390/jcm14041190.


Is there a risk of developmental problems in infants born to mothers with gestational diabetes mellitus and/or pre-eclampsia?.

Yardimci-Lokmanoglu B, Topal Y, Kinaci-Biber E, Arikan Z, Sirtbas-Isik G, Porsnok D PLoS One. 2025; 20(1):e0318003.

PMID: 39854575 PMC: 11760038. DOI: 10.1371/journal.pone.0318003.


Effects of magnesium sulfate combined with labetalol on vascular endothelial function and pregnancy outcomes in pregnant women with preeclampsia.

Liu Y, Li W, Sun Y, Wang Z Am J Transl Res. 2024; 16(11):7096-7106.

PMID: 39678550 PMC: 11645566. DOI: 10.62347/COZZ1407.


Preeclampsia: Etiology, Pathophysiology, Risk Factors, Impact and Prevention: A Narrative Review.

Mustary M, Ansariadi , Syam A, Riskiyani S, Erika K, Moedjiono A Iran J Public Health. 2024; 53(11):2392-2403.

PMID: 39619908 PMC: 11607152. DOI: 10.18502/ijph.v53i11.16941.


References
1.
Duley L, Henderson-Smart D, Knight M, King J . Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ. 2001; 322(7282):329-33. PMC: 26574. DOI: 10.1136/bmj.322.7282.329. View

2.
Wen S, Chen X, Rodger M, White R, Yang Q, Smith G . Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol. 2008; 198(1):45.e1-7. DOI: 10.1016/j.ajog.2007.06.067. View

3.
Roberts J, Balk J, Bodnar L, Belizan J, Bergel E, Martinez A . Nutrient involvement in preeclampsia. J Nutr. 2003; 133(5 Suppl 2):1684S-1692S. DOI: 10.1093/jn/133.5.1684S. View

4.
Olsen O . The impact of global health initiatives on trust in health care provision under extreme resource scarcity: presenting an agenda for debate from a case study of emergency obstetric care in Northern Tanzania. Health Res Policy Syst. 2010; 8:14. PMC: 2891741. DOI: 10.1186/1478-4505-8-14. View

5.
Richard F, Witter S, De Brouwere V . Innovative approaches to reducing financial barriers to obstetric care in low-income countries. Am J Public Health. 2010; 100(10):1845-52. PMC: 2936984. DOI: 10.2105/AJPH.2009.179689. View